Gain Therapeutics, Inc. (GANX)
NASDAQ: GANX · Real-Time Price · USD
2.025
+0.075 (3.85%)
May 8, 2025, 4:00 PM EDT - Market closed

Gain Therapeutics Statistics

Total Valuation

GANX has a market cap or net worth of $56.27 million. The enterprise value is $46.54 million.

Market Cap 56.27M
Enterprise Value 46.54M

Important Dates

The next estimated earnings date is Tuesday, May 13, 2025, before market open.

Earnings Date May 13, 2025
Ex-Dividend Date n/a

Share Statistics

GANX has 27.79 million shares outstanding. The number of shares has increased by 75.86% in one year.

Current Share Class 27.79M
Shares Outstanding 27.79M
Shares Change (YoY) +75.86%
Shares Change (QoQ) +4.42%
Owned by Insiders (%) 4.81%
Owned by Institutions (%) 7.62%
Float 26.45M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS 472.87
PB Ratio 7.49
P/TBV Ratio 7.81
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.97, with a Debt / Equity ratio of 0.09.

Current Ratio 2.97
Quick Ratio 2.85
Debt / Equity 0.09
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -204.95% and return on invested capital (ROIC) is -117.83%.

Return on Equity (ROE) -204.95%
Return on Assets (ROA) -82.80%
Return on Invested Capital (ROIC) -117.83%
Return on Capital Employed (ROCE) -247.90%
Revenue Per Employee n/a
Profits Per Employee -$816,448
Employee Count 25
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, GANX has paid $536,815 in taxes.

Income Tax 536,815
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -30.17% in the last 52 weeks. The beta is 0.17, so GANX's price volatility has been lower than the market average.

Beta (5Y) 0.17
52-Week Price Change -30.17%
50-Day Moving Average 1.96
200-Day Moving Average 1.87
Relative Strength Index (RSI) 54.27
Average Volume (20 Days) 315,620

Short Selling Information

The latest short interest is 279,721, so 1.01% of the outstanding shares have been sold short.

Short Interest 279,721
Short Previous Month 302,677
Short % of Shares Out 1.01%
Short % of Float 1.06%
Short Ratio (days to cover) 0.96

Income Statement

Revenue n/a
Gross Profit -10.65M
Operating Income -20.36M
Pretax Income -21.54M
Net Income -20.41M
EBITDA -20.32M
EBIT -20.36M
Earnings Per Share (EPS) -$0.89
Full Income Statement

Balance Sheet

The company has $10.39 million in cash and $653,015 in debt, giving a net cash position of $9.73 million or $0.35 per share.

Cash & Cash Equivalents 10.39M
Total Debt 653,015
Net Cash 9.73M
Net Cash Per Share $0.35
Equity (Book Value) 7.34M
Book Value Per Share 0.27
Working Capital 7.69M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$18.87 million and capital expenditures -$22,493, giving a free cash flow of -$18.90 million.

Operating Cash Flow -18.87M
Capital Expenditures -22,493
Free Cash Flow -18.90M
FCF Per Share -$0.68
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

GANX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -75.86%
Shareholder Yield -75.86%
Earnings Yield -36.27%
FCF Yield -33.58%

Analyst Forecast

The average price target for GANX is $8.20, which is 304.94% higher than the current price. The consensus rating is "Strong Buy".

Price Target $8.20
Price Target Difference 304.94%
Analyst Consensus Strong Buy
Analyst Count 5
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) -14.91%
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2